Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 4,801–4,820 of 17,937 drug recalls

Drug Recall Terminated Historical recordClass II

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, a) 90 count (NDC 43598-742-90) and b) 1000 count (NDC 43598-742-10) bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA, , packaged in bottles.

by Dr. Reddy's Laboratories, Inc.

Reason
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Recall initiated
October 5, 2021
Reported by FDA
November 10, 2021
Distribution
Nationwide in the US

View recall →

Drug Recall Terminated Historical recordClass III

Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-435-01.

by Lupin Pharmaceuticals Inc.

Reason
Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.
Recall initiated
October 20, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass III

Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets (3 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-094-41

by MACLEODS PHARMA USA, INC

Reason
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Recall initiated
October 18, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass III

Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-093-41

by MACLEODS PHARMA USA, INC

Reason
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Recall initiated
October 18, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass III

Rizatriptan Benzoate Film Coated Tablets, 10 mg, packaged in a) 12 Tablets (2X6 Unit-Dose Tablets) Blister Packs, NDC 33342-088-45), b) 18 Tablets (3 x 6 Unit-Dose Tablets, NDC 33342-088-41) Rx only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536l Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA

by MACLEODS PHARMA USA, INC

Reason
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Recall initiated
October 18, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass III

Afassco Pain Free Plus X-STRENGTH PAIN RELIEVER (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 Tablets/package, Packaged in 12,000 Packets/Case, PO# 19540, Mfg. for: Afassco Minden, NV 89423 (Shipping Label)

by Ultra Seal Corporation

Reason
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Recall initiated
October 13, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass III

Xpect First aid Extra Strength PAIN AWAY (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 Tablets/package, Packaged in 12,000 Packets/Case, Material# 111519, Mfg. for: Cintas First Aid & Safety, Mason, OH 45040 (Shipping Label)

by Ultra Seal Corporation

Reason
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Recall initiated
October 13, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass III

Advance Formula Pain Reliever (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 tablets Per Packet, Packaged in 12,000 Packets/Case, PO# 007564-00, Item# 1170, Mfg. for: Advanced First Aid, Baltimore, MD 21237; American Safety & First Aid, Osceola, IN 46561 (Shipping Label)

by Ultra Seal Corporation

Reason
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Recall initiated
October 13, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass III

North by Honeywell PAIN STOPPER EXTRA STRENGTH (Acetaminophen 250 mg, Aspirin 250 mg, Caffeine 65 mg) tablets, 2 tablets per packet, Packaged in 5,000 Packets/Case, PO# B121242, Item# 853500-01, Dist. By Honeywell Safety Products USA, Smithfield, RI 02917

by Ultra Seal Corporation

Reason
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Recall initiated
October 13, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass III

AERO Tab PAIN RELIEVER (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets , 2 tablets Per Packet, Packaged in 10,000 Packets/Case, PO# 11938, Mfg. for: Aero Healthcare, Valley Cottage, NY 10989 (Shipping Label )

by Ultra Seal Corporation

Reason
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Recall initiated
October 13, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass III

ZEE+ painaid ESF Extra-Strength Formula (Acetaminophen 250 mg, Aspirin 250 mg (NSAID), Caffeine 65 mg) tablets, 2 Tablets per/package, Packaged in a) 50-count packages/carton, b) 125-count packages/carton, PA-ESF 1414Z, Dist. by: Zee Medical Distributors, LLC Mason, OH 45040 (Shipping Label)

by Ultra Seal Corporation

Reason
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Recall initiated
October 13, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass III

Vica-Cet BACK PAIN RELIEF (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets, 2 tablets/pk, packaged in 10,000 packets, PO# 8967, Mfg. for Tellus/The Provision First Aid Line (Shipping Label)

by Ultra Seal Corporation

Reason
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Recall initiated
October 13, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass III

PainAway II (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets , 2 tablets/pk, packaged in 12,000 Packets/Case, Material # 11161, Mfg. for Respond Industries First Aid, Mason, OH 45040 (Shipping Label)

by Ultra Seal Corporation

Reason
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Recall initiated
October 13, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide in the USA.

View recall →

Drug Recall Terminated Historical recordClass III

AllerClear D-24 hr, (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10/240mg), 15-count blister packs, Manufactured by: Ohm Laboratories Inc., 1385 Livingston Avenue, North Brunswick, NJ 08902, NDC 63981-724-15

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Moisture Limits
Recall initiated
October 12, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass III

Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Moisture Limits
Recall initiated
October 12, 2021
Reported by FDA
November 3, 2021
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

SODIUM SELINITE 200MCG/ML FOR INJ, Rx only, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Recall initiated
August 13, 2021
Reported by FDA
November 3, 2021
Distribution
494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.

View recall →

Drug Recall Terminated Historical recordClass II

PROGESTERONE 100MG/ML MDV OIL INJECTION, Rx only, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Recall initiated
August 13, 2021
Reported by FDA
November 3, 2021
Distribution
494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.

View recall →

Drug Recall Terminated Historical recordClass II

MIT/B12 25/50/50MG/ML 1MG/ML MDV, Rx only, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Recall initiated
August 13, 2021
Reported by FDA
November 3, 2021
Distribution
494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.

View recall →

Drug Recall Terminated Historical recordClass II

MIC/B12A/B6 15/50/100 5MG/50MG/ML MDV, Rx only, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Recall initiated
August 13, 2021
Reported by FDA
November 3, 2021
Distribution
494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.

View recall →

Drug Recall Terminated Historical recordClass II

MIC/B12A 25/50/50MG/ML 1MG/ML MDV, Red Mountain Compounding Rx

by First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Reason
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Recall initiated
August 13, 2021
Reported by FDA
November 3, 2021
Distribution
494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.